Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | F1174L |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | ALK F1174L lies within the protein kinase domain of the Alk protein (UniProt.org). F1174L confers a gain of function to the Alk protein as indicated by constitutive phosphorylation of Alk (PMID: 22072639), transformation activity and increased cell proliferation in culture (PMID: 18923525, PMID: 29533785, PMID: 29907598), and has been demonstrated to occur as a secondary resistance mutation in the context of ALK fusions (PMID: 21030459, PMID: 31452835). |
| Associated Drug Resistance | Y |
| Category Variants Paths |
ALK mutant ALK act mut ALK F1174L ALK mutant ALK F1174X ALK F1174L |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29220831A>G |
| cDNA | c.3520T>C |
| Protein | p.F1174L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.4 | chr2:g.29220831A>G | c.3520T>C | p.F1174L | RefSeq | GRCh38/hg38 |
| NM_004304.5 | chr2:g.29220831A>G | c.3520T>C | p.F1174L | RefSeq | GRCh38/hg38 |
| NM_004304 | chr2:g.29220831A>G | c.3520T>C | p.F1174L | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|